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Human neutrophil defensins, and their analogues incorporating 
anionic, hydrophobic or cationic residues at the N- and Ctermini, were 
synthesized by solid-phase procedures. The synthetic defensins were 
examined for their microbicidal activity against Candida albicans, two 
Gram-negative bacteria (Actinobacillus actinomycetemcomitans and 
Porphyromonas gingivalis) and two Gram-positive bacteria 
(Streptococcus gordonii and Streptococcus mutans). The human 
neutrophil peptide 1 (HNP1) and HNP2 were found to be potent 
candidacidal agents. HNP3, which differs by one amino acid at the N-
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terminus of its sequence, was totally inactive. The Gram-negative 
bacteria A. actinomycetemcomitans and P. gingivalis and the 
Grampositive bacteria S. gordonii and S. mutans were insensitive to 
human defensins. However, the insertion of two basic residues, such 
as arginine, at both the N-terminus and the C-terminus of HNP2 
significantly enhanced antifungal and antibacterial activity. The 
addition of anionic residues, such as aspartic acid, at the N- and C-
termini rendered the molecule totally inactive. The presence of two 
hydrophobic amino acids, such as valine, at the N-terminus of HNP2 
and of two basic arginine residues at its C-terminus resulted in 
molecules that were optimally active against these oral pathogens. The 
results suggest that the N- and C-terminal residues in defensin 
peptides are the crucial functional elements that determine their 
microbicidal potency. The three-dimensional structure of all defensins 
constitutes the same amphiphilic -sheet structure, with the polar face 
formed by the N- and C-terminal residues playing an important role in 
defining microbicidal potency and the antimicrobial spectrum. The 
enhance microbicidal activity observed for defensin peptides with two 
basic residues at both the N- and C-termini could be due to 
optimization of the amphiphilicity of the structure, which could 
facilitate specific interactions with the microbial membranes.  
 
Key words: antimicrobial agents, antiparallel -sheet peptides, cysteine-rich 
cationic polypeptides, defensin analogues, peptide disulphides. 
 
Introduction 
 
The defensins comprise a group of cysteine-rich cationic 
antimicrobial polypeptides that have been identified and characterized 
in animals (including humans), plants and insects. They are composed 
of 29-42 amino acids and contain three disulphide bonds, formed by 
three pairs of cysteine residues [1-4]. Defensins have been isolated 
from various tissue sources, such as mammalian trachea, intestine, 
tongue and skin, and human plasma, oral mucosa, salivary glands, 
saliva and ocular surface [5-13]. Defensins are involved in the oxygen-
independent mechanism of the host immune response [14]. The 
`classic’ or -defensins were the first group of defensins to be isolated 
from human and animal phagocytes, and they comprise a large 
subfamily of polypeptides containing 29-36 residues [3,15]. The more 
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recently isolated -defensins are more basic and longer (34-42 
residues), and are expressed in various mucosa and epithelial cells 
[5,16]. The tri-disulphide motifs in - and -defensins differ [16,17]. 
 
Defensins have been reported to exhibit powerful antibacterial, 
antifungal and antiviral activity against a wide variety of 
microorganisms [17-19]. The antibiotic activity of defensins has 
generally been attributed to their effects on microbial membranes 
[19,20]. They have been reported to interact with lipopolysaccharides 
in Gram-negative bacteria, polysaccharides (teichoic acid) in Gram-
positive bacteria, and phospholipids [17]. The three-dimensional 
structures of a few defensin peptides have been reported in the 
crystalline state [21] and in solution [22-26]. These studies have 
shown that defensins exist as triple-stranded amphiphilic -sheet 
structures in aqueous solution, and that the amphiphilicity of the 
molecule might facilitate their spontaneous insertion into microbial 
membranes, thereby disrupting membrane permeability and integrity 
[24,25]. Recent studies have shown that the mechanism of antibiotic 
activity of defensins could involve both cell membrane and intracellular 
targets [27]. 
 
Variations exist in the sequences of -defensins isolated from 
different biological sources in humans and animals, particularly at the 
N-and C-termini and in the middle portion, as shown in Figure 1. The 
sequence identity, the structure reported for a few -defensins and the 
conserved disulphide constraints suggest that the overall three-
dimensional structure of -defensins is maintained, despite variations 
in individual sequences. However, the differences in -defensin 
sequences have been found to be reflected in their specificity for 
microbes and their spectrum of antimicrobial activity. For instance, 
human neutrophil defensins HNP1 (human neutrophil peptide 1) and 
HNP2 have been reported to be potent candidacidal agents. However, 
HNP3, which differs only in one amino acid at the N-terminus, has 
been found to be least active against C. albicans [28]. HNP1 and HNP2 
have been found to be equipotent in their ability to kill 
Capnocytophaga species, and their activity has been reported to be 
significantly greater than that of HNP3 [29]. Even though human 
defensins (HNP1, HNP2 and HNP3) are not active against Actinobacillus 
actinomycetemcomitans, rabbit defensing NP1, which shows variations 
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at the N- and C-termini and in the middle portion of the sequence, has 
been reported to exert pronounced activity against A. 
actinomycetemcomitans strains [29]. Such wide functional diversity 
has also been observed for rat defensins of similar structure [30]. The 
three-dimensional structure of defensins has been reported to 
primarily assume a `basket-like’ amphiphilic structure. The open end 
of the basket constituted by the N- and C-terminal residues forms the 
polar face, whereas the lower and bottom portion of the basket 
assumes the apolar face of the amphiphilic structure [21,25]. The wide 
functional diversity observed in parallel with variations in the sequence 
at the N- and C-termini seems to indicate that the residues at the 
polar face could be the crucial determinants of microbicidal potency 
and the antimicrobial spectrum. In this paper we describe a new 
method for the large-scale synthesis of -defensins, and investigate 
the influence of their N- and C-terminal residues on their antimicrobial 
spectrum and microbicidal potency. 
 
Experimental 
 
General materials and methods 
 
Chemicals and solvents were of the highest purity available and 
were used without further purification. Amino acid derivatives and p-
benzyloxybenzyl alcohol (Wang) resins were purchased from Sigma 
Chemical Co. (St. Louis, MO, U.S.A.) and Bachem (Torrance, CA, 
U.S.A.). The peptide sequence was assembled using a manual peptide 
synthesizer. HPLC was carried out on a Rainin-HPXL system interfaced 
to a Macintosh SE/30 computer using a Rainin Dynamax C18 column 
(10 mm х 250 mm) coupled to a guard column (10 mm х 50 mm) and 
employing acetonitrile/water [each containing 0.1% trifluoroacetic acid 
(TFA)] linear gradient elution with a flow rate of 2.0 ml·min−1. The 
dried peptide was hydrolysed in sealed tubes for 24 h at 110°C using 6 
M HCl in the presence of 1% phenol vapour, and amino acid analysis 
was performed on a Perkin—Elmer 420A derivatizer and analyser 
system. The amino acid sequence of the peptide (~1 nmol) was 
checked by sequence analysis using a Perkin—Elmer Model 477A 
protein sequencer. Fast-atom bombardment (FAB) mass analysis was 
carried out on an M-Scan VG Analytical ZAB 2-SE high-field mass 
spectrometer. A caesium ion gun was used to generate ions for the 
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acquired spectra, which were recorded using a PDP 11-250J data 
system. 
 
Peptide synthesis and purification 
 
The linear defensin sequences (HNP1, HNP2, HNP3, HNPa, HNPb, 
HNPc, HNPd and HNPe) shown in Figure 1 were assembled by standard 
solid-phase procedures [31] using Wang resins linked to the C-
terminal Fmoc (9-fluorenylmethyloxycarbonyl) amino acid (0.2-0.3 
mmol/g). The general scheme employed for the synthesis of defensin 
peptides is shown in Scheme 1. The side-chain protecting groups were 
the following: Glu, Thr and Tyr, O-tButyl; Trp, tBoc (t-
butyloxycarbonyl); Arg, N-2,2,5,7,8-pentamethylchroman-6-
sulphonyl; N- and C-terminal Cys, Trityl ; Cys-4 and Cys-19, S-tButyl; 
Cys-9 and Cys-29, acetamidomethyl (Acm). The coupling reactions 
were carried out with a 3-fold excess of Fmoc amino acid in a mixture 
(50%, v/v) of N,N-dimethylformamide and dichloromethane using 
dicyclohexylcarbodi-imide as the coupling reagent in the presence of 
1-hydroxybenzotriazole. Completion of the coupling reaction was 
monitored by Kaiser's test [32]. The Fmoc group on the N-terminus 
was deprotected in 10 min with a 25% solution of piperidine in 
dimethylformamide. The protected peptidyl resin was then treated with 
90% (v/v) TFA in dichloromethane containing thioanisole (2.5%) and 
dimethyl sulphide (2.5%). When the peptide was cleaved from the 
resin, the crude linear peptide (93-95%) was obtained. The N- and C-
terminal Cys residues with the S-Trityl protecting group were 
deprotected at the same time when the peptide was cleaved from the 
resin by treatment with TFA, whereas the Acm and S-tButyl protecting 
groups on Cys-4/Cys-19 and Cys-9/Cys-29 respectively were intact. 
The crude linear peptides were purified by reverse-phase HPLC on a 
Rainin Dynamax-60A C18 column (10 mm х 250 mm) coupled to a 
guard column (10mm х 50 mm) employing acetonitrile/water (each 
containing 0.1% TFA) linear gradient elution (10-50% acetonitrile in 
water over a period of 45-50 min) with a flow rate of 2.0 ml·min−1 
(detection at 230 nm and 280 nm). The fractions of each resolved 
peak were pooled, lyophilized and subjected to amino acid and 
sequence analyses, which identified and verified the authentic peptide 
sequence. 
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Disulphide-bond formation between the N- and C-
terminal cysteine residues 
 
The HPLC-purified linear peptide (0.45 g) with free thiol groups 
on the N- and C-terminal cysteine residues was suspended in 2.5 litres 
of water to bring the concentration of the peptide to ~0.05 mM, and 
the pH was brought to 6.8 by the addition of 0.1M ammonium acetate 
solution. A 0.2 M solution of potassium ferricyanide was added in 
minute drops over a period of 12 h while maintaining the pH at 6.8-
7.0, until the yellow colour persisted. A 5 ml excess of potassium 
ferricyanide was then added to ensure oxidation. The pH of the 
solution was maintained at 6.8-7.0 by using 0.1 M ammonium acetate 
and 20% acetic acid. The solution was concentrated to 50 ml at 40-
45°C and then passed through an activated thiol-Sepharose 4B resin 
(Amersham Pharmacia Biotech, Piscataway, NJ, U.S.A.) column (10 
mm х 75 mm) to remove any peptide containing free thiol groups. The 
peptide from the column was eluted with 0.1 M ammonium acetate 
buffer (pH 6.8). The aqueous peptide solution was pooled and 
lyophilized. The dried material was purified by reverse-phase HPLC 
using the semi-preparative Rainin Dynamax-60A C18 column, as 
described above. The fractions of the major well resolved peak were 
pooled, lyophilized and subjected to amino acid and sequence 
analyses. The amino acid composition, sequence and mass-spectral 
analysis of the purified material verified the correct sequence. The 
yield of the purified product was found to be 66-68%.  
 
Disulphide-bond formation between Cys-4 and Cys-19 
 
The purified material obtained as described above was dissolved 
in trifluoroethanol (300 ml) and reduced with 12.3 ml of 
tributylphosphine at room temperature for 3 h to deprotect the S-
tButyl groups on Cys residues at positions 4 and 19 (Scheme 1). The 
reaction mixture was then concentrated to a small volume (2 ml) and 
the product was precipitated by the addition of diethyl ether. The 
separated solid was filtered and washed with ether (3 х 25 ml) and 
dried. The dried material (~0.35 g) was suspended in 2.0 litres of 
water to bring the peptide concentration to 0.05 mM and then 
subjected to oxidation using a 0.2 M solution of potassium ferricyanide 
at pH 6.8, and the peptide was isolated as described in the previous 
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section. The dried material was subjected to reverse-phase HPLC and 
the fractions of the major resolved peak were pooled and analysed. 
The amino acid composition, sequence and mass-spectral analyses 
identified the peptide. The yield of the purified product was found to be 
56-58%. 
 
Disulphide-bond formation between Cys-9 and Cys-29 
 
The total material obtained after the formation of the second 
disulphide bond (~0.3 g) was dissolved in a mixture of water/methanol 
(6 :1, v/v) so that the peptide concentration was 0.05 mM. The 
peptide solution was stirred while adding a 1 mM solution of iodine 
(125 ml) in methanol dropwise during 1 h. The red solution was cooled 
to 0 °C and treated with 1 M sodium thiosulphate until the red colour 
disappeared. The methanol was removed by rotary evaporation at the 
water aspirator and then the material was lyophilized. The crude 
material obtained was dissolved in 50 ml of water and passed through 
an activated thiol-Sepharose B column (5 mm х 75 mm); the column 
was then washed with (3 х 25 ml) 0.1 M ammonium acetate buffer at 
pH 6.8. The aqueous solution was lyophilized. The dried material was 
purified by reverse-phase HPLC as described above. All fractions of the 
well-resolved peaks were pooled and lyophilized. The sequence, mass-
spectral and amino acid analyses of the major component identified it 
as the synthetic defensin sequence. The identity of the synthetic 
peptide was assessed by comparing its HPLC retention time, CD 
spectrum and mass spectrum with those of the native defensin 
peptides isolated from human neutrophils. The yield of the product 
after HPLC purification was found to be 45-48%. 
 
Organisms and growth conditions 
 
Candida albicans strain ATCC 28366 obtained from the American 
Type Culture Collection (Rockville, MD, U.S.A.) and a clinical isolate 
from a patient with denture-induced stomatitis (DIS) were used. The 
identity of the clinical isolate was verified by the Yeast System (Flow 
Laboratories, McLean, VA, U.S.A.). Organisms were streaked on to 
Sabouraud Dextrose Agar plates (Difco Laboratories, Detroit, MI, 
U.S.A.) and maintained at 4°C. One colony of C. albicans from this 
plate was inoculated into 10 ml of yeast synthetic growth medium 
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containing sucrose, salts and biotin [33], and incubated for 48 h at 
25°C in a shaker rotating at 200 rev./min. After this period, the 
population of yeast cells was in late-exponential-phase growth. Cell 
morphology was determined by phase-contrast microscopy and found 
to be uniformly blastospores. Subcultures were done every 3 days by 
inoculating 100 l of 3-day-old culture into 10 ml of fresh synthetic 
medium. 
 
Measurement of candidacidal activity 
 
The antifungal activity of the synthetic human neutrophil 
defensins and their analogues was assessed in vitro against Candida 
albicans. The loss of cell viability is expressed as a function of peptide 
concentration. The assay was performed as described for the 
candidacidal activity of salivary histatin 5 and its fragments [34]. We 
refer to the rapid candidacidal action of peptides as a loss of viability 
of cells, since inability of the yeast to replicate following removal of 
peptides is considered to represent a non-viable cell. Thus the assay 
used in the present study measured only fungicidal activity. Cells from 
48 h cultures were harvested, washed and resuspended to a 
concentration of 5 х 107 cells/ml in 0.01 M sodium phosphate buffer 
(pH 7.4). Stock solutions of peptides (range 0.05-200 M) were made 
in 0.01 M sodium phosphate buffer. Peptide concentrations were 
determined by amino acid analysis. A microassay system was utilized 
in which 100 l of the stock solution of test peptide was incubated with 
100 l (5 х 106 cells) of yeast suspension in sterile glass test tubes at 
37°C for 1.5 h. Control suspensions consisting of 100 l of cells and 
100 l of sodium phosphate buffer were incubated simultaneously. 
Each tube of cell suspension was shaken for 10 s every 15 min during 
this time. A 100 l aliquot of cells was removed from the tube, diluted 
to 5 х 102 cells/ml in sodium phosphate buffer and then vortex-mixed. 
Aliquots of 0.5 ml of each suspension were spread on to plates (15 
mm х 100 mm) of Sabouraud Dextrose Agar in duplicate. C. albicans 
was grown overnight at 37°C, and the candidacidal activity of the test 
peptide was assessed as the ratio of colonies per test plate to the 
number of colonies on control (no peptide) plates, and expressed as a 
percentage. 
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Bacterial strains and cultivation 
 
The cultivation of bacterial strains was carried out as described 
in our previous publications [35,36]. Briefly, Porphyromonas gingivalis 
strains W50 and 381 were maintained on blood agar plates containing 
tryptic soy agar (Difco Laboratories) supplemented with hemin (1%), 
menadione (0.02%) and de-fibrinated sheep blood (5%).  
Actinobacillus actinomycetemcomitans strains Y4 and 67 were 
maintained in tryptic soy agar plates containing yeast extract (0.5%). 
Streptococcus mutans GS5 and Streptococcus gordonii DL1 were 
grown on Todd-Hewitt agar plates. For liquid culture, these bacteria 
were grown in their respective broth. All experiments were carried out 
in an anaerobic chamber (85% N2, 10% H2 and 5% CO2) (Coy 
Laboratory Products), and bacteria were confirmed routinely by 
standard microbiological methods. 
 
Bactericidal assay 
 
The bactericidal assays were performed as described previously 
[35,36]. The antimicrobial activity of defensins was tested against P. 
gingi.alis (W50 and 381), A. actinomycetemcomitans (Y4 and 67), S. 
gordonii (GS5) and S. mutans (DL1). Bacterial strains were grown in 
freshly prepared broth to 109 cells and subsequently diluted to 106 
cells/ml in 10 mM sodium phosphate buffer (pH 7.4). Cells were 
harvested and washed twice in sodium phosphate buffer. Washed cells 
were incubated with various concentrations of the peptide in a total 
volume of 200 l at 37°C in an anaerobic chamber for 1.5 h as 
described previously [36]. The cells were diluted to 103 cells/ml and 
plated on the respective agar plates. The plates were incubated 
anaerobically at 37°C for 6 days, and the number of viable P. 
gingivalis colonies was calculated in comparison with the control. In 
the case of A. actinomycetemcomitans, S. gordonii and S. mutans, the 
colonies were counted after 3 days and compared with the control 
plates. The bactericidal activity of the peptide was expressed as [1—
(cell survival after peptide incubation)/(cell survival in buffer alone)] х 
100, which represents the percentage killing of the bacterial cells. The 
loss of cell viability is expressed as a function of peptide concentration. 
The peptide concentration that induced 90% of the maximal loss of cell 
viability (EI90) was determined from the concentration-effect curves.  
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Purification of native human neutrophil defensins 
 
In order to determine the identity of the synthetic molecules 
and to verify the formation of correct disulphide bonds between the 
respective cysteine residues, we purified a few native human 
defensins. Human neutrophils were isolated from whole blood collected 
from healthy human volunteers, as described in our previous 
publication [37]. Cell purity (90-95% neutrophils) was assessed by 
Wright-Giemsa staining. Leucocytes were homogenized, centrifuged 
and chromatographed using the method reported previously [38]. The 
mixture of HNP1, HNP2 and HNP3 obtained after initial 
chromatographic separation was subjected to reverse-phase HPLC on a 
Rainin Dynamax-60A semi-preparative C18 column (10 mm х 250 
mm) coupled to a guard column (10 mm х 50 mm) employing  
acetonitrile/water (each containing 0.1% TFA) linear gradient elution 
(flow rate 2.0 ml·min−1). Processing of 2.8 х 109 cells yielded ~4.5, 
4.0 and 4.2 mg of HNP1, HNP2 and HNP3 respectively. The 
homogeneity of peptides was examined by reverse-phase HPLC on a 
Rainin Dynamax-60A analytical C18 column (4.6 mm х 250 mm) 
coupled to a guard column (4.6 mm х 15 mm) employing 
acetonitrile/water (each containing 0.1% TFA) linear gradient elution 
(flow rate 0.8 ml·min-1) with detection at 230 nm and 280 nm. The 
native molecules were further verified by SDS/PAGE, cationic PAGE, 
amino acid analysis and FAB-MS analysis. 
 
CD spectroscopy 
 
CD measurements were carried out on an Aviv 62DS spectro-
polarimeter equipped with a thermostatic temperature controller and 
interfaced to an IBM microcomputer. CD spectra were recorded in a 
quartz cell of 0.05 mm pathlength at 30°C between 180 and 250 nm, 
using a 1.0 nm bandwidth and a scanning rate of 10 nm/min with a 
wavelength step of 0.2 nm and a time constant of 2 s. The region from 
250 to 400 nm was recorded using a 1 mm pathlength cell. Peptides 
were dissolved in 10 mM sodium phosphate buffer at pH 7.2 to a 
concentration of 0.1-0.3 mM. CD band intensities were determined as 
molar ellipticity ([θ]M), in deg·cm2·dmol−1. 
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RESULTS AND DISCUSSION 
 
Synthesis of defensin peptides 
 
The method described for the synthesis of defensin peptides 
yielded nearly 17-20% of final purified product. The identity of the 
synthetic molecules was verified by comparing the SDS/PAGE and 
cationic PAGE profiles and the CD and FABMS spectra with those of the 
native peptides. The FAB mass spectra of synthetic and native HNP1 
showed the molecular ion cluster centered at m/z 3442, which is 
consistent with the molecular mass. The intensity of the disulphide n-
σ* CD bands that generally occur between 250 and 320 nm is highly 
sensitive to the dihedral angle, flexibility and chirality of the disulphide 
chromophore [39,40]. Hence we examined the CD bands in this region 
for both synthetic peptides and native molecules. The CD spectra of 
synthetic and native HNP1 in the region 250-400 nm, which reflects 
the contribution of disulphide n-σ* and of aromatic residues, were 
comparable. The CD spectra of the synthetic and native HNP1 in the 
region between 180 and 250 nm, which represents the peptide 
secondary structure, were almost identical. Analysis on SDS/12.5%-
PAGE indicated that the native and synthetic molecules migrated to 
the same extent. In addition, the microbicidal activity of synthetic and 
native HNP1 (described in subsequent sections) were also comparable. 
Collectively, the data suggest that the synthetic molecules are identical 
with the native peptides. 
 
The formation of the three distinct disulphide bonds between the 
respective cysteine residues is the major task in the synthesis of 
defensins. Simultaneous oxidation of the six thiol groups might lead to 
the formation of undesired disulphide bridges and polymerized side-
products, leading to a very poor yield of defensins. We found a high 
percentage of polymerized sideproducts when all six thiol groups were 
oxidized simultaneously, even at very low peptide concentration. The 
formation of undesired polymerized side-products during the 
simultaneous oxidation of all six or four cysteine residues has been 
reported [41], although it might be possible to purify trace amounts of 
the correct peptide from these side-products [42]. Therefore we 
rationally selected three different protecting groups, namely Trityl (for 
N- and C-terminal cysteines), S-tButyl (for Cys-4 and Cys-19) and 
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Acm (for Cys-9 and Cys-29), for the three pairs of cysteine residues 
that form the disulphide bonds. The three thiol protecting groups were 
deprotected under different conditions in three different stages and 
oxidized to form the respective disulphide bridges, as described in 
Scheme 1. Reverse-phase HPLC traces of the crude peptide with one 
disulphide bond between Cys-1 and Cys-30, of that with two 
disulphides between Cys-1 and Cys-30 and between Cys-4 and Cys-
19, of the crude HNP1 and of the purified HNP1 are provided in Figure 
2.  
 
The scheme employed for the synthesis of defensins eliminates 
the formation of any undesired disulphide bonds.Wefirst cyclized the 
peptide by forming the disulphide bridge between the N- and C-
terminal cysteines, thereby allowing the other cysteine residues to 
achieve a favourable orientation in space to ease the formation of 
disulphide bonds between the respective cysteine residues. The three-
dimensional structure of defensins clearly suggests that the folding of 
the C-terminus towards the N-terminus brings the other two pairs of 
cysteine residues into close proximity, favouring the formation of the 
disulphide bonds [21,25]. Hence we chose to form the first disulphide 
bridge between the N- and C-terminal Cys residues. The trace 
amounts of any free thiolcontaining sequences at each stage of 
formation of disulphide bonds were removed by treatment with a 
column of activated thiol-Sepharose 4B resin (Amersham Pharmacia 
Biotech), which selectively adsorbs even trace amounts of thiol-
containing sequences. The use of activated thiol-Sepharose 4B resin at 
each stage of formation of disulphide bonds eliminates the 
accumulation of any thiol-containing products. The oxidation of 
cysteine residues in all three different stages was carried out in 
solution at a peptide concentration of 0.05 mM, with vigorous stirring 
to minimize polymerization. Chemical synthesis of a few defensing 
peptides using only two different protecting groups, and formation of 
disulphide bonds in two stages, has been reported previously, with a 
final yield of only 7% [41]. The simultaneous removal of the protecting 
groups on four cysteine residues and oxidation of the thiol groups 
might have led to the formation of undesired side-products, and 
accordingly lowered the percentage yield of the products. The method 
described in this paper, using three distinct thiol protecting groups and 
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forming disulphide bonds in three different stages, is very efficient, 
giving a high yield (17-20%) of pure defensin peptides. 
 
Candidacidal activity 
 
The efficacy of defensin peptides in inducing loss of viability of 
Candida albicans was measured at various peptide concentrations 
(Figure 3). The data provided in Figure 3 are for the DIS strain; C. 
albicans strain 28366 has been found to be 10-20% more susceptible 
to these peptides. The percentage loss of viability of C. albicans 
induced by synthetic HNP1 at various concentrations (Figure 3) is 
comparable with that observed for the native molecule, suggesting 
identity of the molecules. The EI90 value for HNP1 was ~14 M. The 
candidacidal activity of HNP2 was nearly 5-fold lower than that of 
HNP1. The EI90 for HNP2, which lacks the N-terminal Ala residue, was 
~65 M, indicating the importance of the residues preceding cysteine 
at the N-terminus. The Candida albicans strains were insensitive to 
HNP3, which has a negatively charged Asp residue at this position. The 
results are consistent with the previously reported candidacidal activity 
of human defensins [28], although the C. albicans strains and the 
assay procedures used were different. 
 
HNPa, which has two Asp residues at both the N- and the C-
terminus, was totally inactive against C. albicans, suggesting that 
negatively charged side chains at the termini render the molecule 
inactive. Compared with HNP1, a 5-fold increase in candidacidal 
activity was observed when two polar amino acids, such as threonine, 
were present at the N- and C-termini, as in the case of HNPc (EI90 ~ 3 
M). HNPb, which has two hydrophobic valine residues at the N-
terminus and two cationic arginine residues at the C-terminus, had 2-
fold greater candidacidal activity (EI90 ~ 6 M). Compared with HNPb, 
a 2-fold increase in candidacidal activity was observed for HNPd (EI90 
~ 1.5 M), which has two threonine residues in place of valines at the 
N-terminus. The presence of two arginine residues at both the N- and 
the C-terminus enhanced candidacidal activity significantly : HNPe 
(EI90 ~ 0.5 M) was 10-fold more potent than HNPb, and markedly 
(30-fold) more active than HNP1. Collectively, the candidacidal 
activities of human defensins and their analogues suggest that polar 
and charged side chains at the N- and C-termini, respectively 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biochemical Journal, Vol. 347, No. 3 (May 2000): pg. 633-641. DOI. This article is © Portland Press Limited and permission 
has been granted for this version to appear in e-Publications@Marquette. Portland Press Limited does not grant 
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from 
Portland Press Limited. 
14 
 
preceding and succeeding the cysteine residues, appear to be 
functionally very important.  
 
Bactericidal activity 
 
The microbicidal activities of human neutrophil defensins and 
their analogues against the Gram-negative P. gingivalis and A. 
actinomycetemcomitans strains are summarized in Figures 4 and 5 
respectively. P. gingivalis (strains W50 and 381) and A. 
actinomycetemcomitans (strains Y4 and 67) were insensitive to human 
neutrophil defensins HNP1, HNP2 and HNP3 up to a peptide 
concentration of 200 M. The strains were also insensitive to the 
analogue HNPa, which has two Asp residues at both the N- and C-
termini. Both P. gingivalis and A. actinomyctemcomitans strains were 
highly sensitive to the analogues HNPb, HNPc, HNPd and HNPe, which 
have two additional residues at the N- and C-termini of human 
defensing peptides (Figures 4 and 5). HNPb, which has two 
hydrophobic valines preceding the cysteine at the N-terminus and two 
arginines following the cysteine at the C-terminus, was microbicidal 
against both P. gingivalis and A. actinomycetemcomitans (Figures 4 
and 5). The EI90 for this peptide was ~ 25 M. This HNPb peptide is 
similar to rabbit defensin peptide NP1, which has two valine and two 
arginine residues at the N- and C-termini respectively. However, NP1 
has variations in the middle portion of the sequence as compared with 
human defensins HNP1, HNP2 and HNP3 (Figure 1). Therefore the 
comparable cidal activities of HNPb and NP1 seem to indicate that the 
residues at the N- and C-termini of defensin peptides may be 
functionally very important for microbicidal activity and specificity. The 
microbicidal activity of NP1 against A. actinomycetemcomitans 
reported previously is comparable with our present results with HNPb 
[29]. 
 
The presence of two polar side chains, such as threonine 
residues, at the N- and C-termini of human defensins also elicited 
similar antimicrobial activity against these two Gram-negative bacteria 
(Figures 4 and 5). However, the presence of threonines appeared to 
increase the cidal potency slightly. The EI90 for HNPc was ~ 14 M, 
suggesting an approx. 2-fold increase in microbicidal activity as 
compared with HNPb. The presence of two threonine residues at the N-
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terminus and two arginine residues at the C-terminus, as in the case 
of HNPd (EI90 ~ 5 M), enhanced the activity 5-fold as compared with 
HNPb (Figures 4 and 5). The addition of two polar and charged 
arginine residues at the N- and C-termini, as in the case of HNPe (EI90 
~ 1 M), enhanced microbicidal activity 25-fold as compared with 
HNPb (Figures 4 and 5). 
 
Thus, even though HNP1 and HNP2 are potent antifungal agents 
against C. albicans, they are minimally active against the Gram-
negative bacteria P. gingivalis and A. actinomycetemcomitans. The 
insertion of two valine side chains at the N-terminus and two arginine 
residues at the C-terminus of HNP2 elicits antibacterial activity against 
these organisms. This suggests that the additional N- and C-terminal 
side chains are indeed necessary to elicit optimal antibacterial activity 
against these organisms. Comparison of the activities of HNPb, HNPc, 
HNPd and HNPe suggests that the antibacterial activity tends to 
increase with the increase in polarity caused by the additional residues 
at the N- and C-termini. The data suggest that the presence of two 
additional polar and charged side chains preceding and following the 
cysteine residues at the N- and C-termini respectively of human 
defensins is required for optimal antibacterial activity. 
 
Streptococcus gordonii (strain GL1) and Streptococcus mutans 
(strain GS5) were also insensitive to the human neutrophil defensins 
HNP1, HNP2 and HNP3 and the analogue HNPa. However, both strains 
were sensitive to HNPb, HNPc, HNPd and HNPe (Figure 6), at slightly 
higher concentrations than were required for activity against the 
Gram-negative bacteria P. gingi.alis and A. actinomycetemcomitans. 
At a concentration of 55 M, 90% killing was observed for HNPb. HNPc 
(EI90 ~ 27 M), which has two polar threonine residues at both the N- 
and C-termini, was slightly (2-fold) more active than HNPb. HNPd, 
which has two threonines and two arginines at the N- and C-termini 
respectively, was nearly 5-fold more active (EI90 ~ 15 M) than HNPb 
(Figure 6). The presence of two arginines at both the N- and C-termini 
caused HNPe to be significantly more active (EI90 ~ 6 M) than HNPb. 
 
The trend for the increase in microbicidal activity with sequence 
alterations at their N- and C-termini appears to be the same for Gram-
positive and Gram-negative organisms (Figure 6). In other words, the 
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antibacterial activity of defensin peptides increases with an increase in 
the cationic charge and polarity of the residues preceding and 
following cysteine residues at the N- and C-termini respectively. The 
slight differences in the cidal potencies of the defensin analogues 
observed for Gram-negative as compared with Gram-positive 
organisms could be due to differences in membrane structure and 
composition of lipids. Defensin-like peptides have been reported to 
have better antimicrobial activity against Gram-negative bacteria, and 
their activity has been related to their ability to permeabilize the outer 
membrane [43,44]. 
 
Molecular structure and antimicrobial activity 
 
-Defensins isolated from various biological sources in humans 
and animals show conservation of the three disulphide bridges and 
retain nearly 50% sequence identity. There are variations in the 
sequences at the N- and C-termini and in the middle portion of these 
peptides. These differences have been found to be reflected in their 
antimicrobial spectrum and specificity of organisms for which they are 
cidal [14,28]. This functional diversity observed for similarly structured 
molecules raises interest in identifying the crucial residues responsible 
for their specificity and antimicrobial potency. Hence we selected the 
human neutrophil defensins HNP1, HNP2 and HNP3, which have 
identical sequences from the N-terminal cysteine to the Cterminal 
cysteine, and examined analogues with minor variations only at the N- 
and C-termini, to assess unambiguously the influence of terminal 
residues on their antimicrobial spectrum and antimicrobial potency.  
 
HNP2, which does not have any additional residues preceding 
the N-terminal cysteine or following the C-terminal cysteine (Figure 1), 
is an optimally active candidacidal agent. The presence of an Ala 
residue at the N-terminus enhances the candidacidal activity, as 
observed in the case of HNP1 (Figure 3). On the other hand, the 
presence of a negatively charged Asp residue at this position (HNP3) 
renders the molecule totally inactive against C. albicans. HNP1, HNP2 
and HNP3 do not exhibit any microbicidal activity against the Gram-
negative bacteria P. gingivalis and A. actinomycetemcomitans or the 
Gram-positive bacteria S. gordonii and S. mutans. The same effect is 
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observed for HNPa, which has two Asp residues at both the N- and C-
termini, indicating that negative charge at these positions renders 
defensins inactive. However, the presence of two valines at the 
N-terminus and two arginines at the C-terminus renders human 
defensins active against the Gram-negative and Gram-positive 
organisms examined in this investigation. Antibacterial potency is also 
enhanced by the presence of polar residues, such as threonine, and 
significantly enhanced by the presence of positively charged arginine 
residues, as shown by the relative antibacterial and candidacidal 
activities of HNPb, HNPc, HNPd and HNPe (Figures 3-6). An arginine 
residue has a hydrophobic hydrocarbon chain attached to a polar and 
charged guanidine function. The enhanced microbicidal activity 
observed for HNPe, and comparison of its activity with that of the 
other analogues, seems to suggest that the interactions of defensins 
with microbes could involve hydrophobic, hydrogen-bonding and 
electrostatic interactions. It is also possible that an increase in the 
cationic charge preceding the N-terminal cysteine and following the C-
terminal cysteine could be an important determinant of the 
antimicrobial spectrum and microbicidal potency of the defensins. 
However, residues with polar side chains, such as threonine, in these 
positions also elicit high cidal potency against the organisms tested, as 
shown by the microbicidal activities of HNPc and HNPd. 
 
The three-dimensional structure of defensins established by X-
ray diffraction and NMR studies contains an amphiphilic three-stranded 
antiparallel -sheet structure [21,24,25]. The molecules assume a 
basket-like structure. The open end of the basket constituted by the N- 
and C-terminal residues forms the polar face, whereas the lower and 
bottom portion of the basket assumes the apolar face of the 
amphiphilic structure. The presence of two residues both preceding 
and following the cysteines at the N- and C-termini respectively might 
not alter the overall three-dimensional structure of the molecules. The 
enhanced activity of defensin analogues with an additional two 
residues at both the N- and C-termini suggests that the projecting side 
chains at the polar face of the amphiphilic structure could, indeed, be 
crucial requirements for their specificity and microbicidal activity. The 
increase in microbicidal activity observed for analogues with polar and 
charged residues at the N- and C-termini correlates with an increase in 
polarity of the polar face of the amphiphilic structure. Similar effects 
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may be observed by altering the hydrophobicity of the apolar face of 
the amphiphilic molecule. However, additional data are required to 
support this argument. Nevertheless, the present data provide support 
for the proposal that the N- and C-terminal residues preceding and 
following the cysteine residues respectively are important functional 
elements for the antimicrobial spectrum and microbicidal potency of 
defensins. This could be due to an alteration in the amphiphilicity of 
the molecule that might have a profound influence on microbial 
membranes, which differ in their structure and lipid composition 
depending on the micro-organisms involved.  
 
In summary, the synthetic scheme described in this paper 
represents a convenient procedure for the large-scale synthesis of 
defensins, which have potential applications in the pharmaceutical 
industry. The present studies suggest that the two residues at the N- 
and C-termini that respectively precede and follow cysteine residues 
could be the determinants of the microbicidal potency and the 
antimicrobial spectrum of defensins. Attempts to compromise the 
amphiphilicity of the defensin structure by altering the polarity of the 
polar face appear to significantly modify specificity and microbicidal 
potency. Hence, by rationally choosing these residues, it should be 
posssible to obtain potent antimicrobial agents to target selected 
infectious pathogens.  
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Figure 1 Amino acid sequences of human (HNP) and rabbit (NP) defensins and 
synthetic analogues  
 
The one-letter symbols are used for amino acids in the sequences [45]. 
Conserved amino acid residues are in bold and underlined. The broken lines 
indicate the disulphide bridges between the respective cysteine residues. 
HNP1, HNP2 and HNP3 are native peptides; HNPa, HNPb, HNPc, HNPd and 
HNPe are synthetic analogues. 
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Scheme 1 Scheme and protecting groups employed for the synthesis of 
human neutrophil defensins and their analogues 
 
The sequence shown in the scheme is that of HNP1. tBu, tertiarybutyl ; Trt, 
Trityl ; Xa, O-tButyl ; Xb, N-2,2,5,7,8-pentamethylchroman-6-sulphonyl ; Xc, 
N-Trityl ; Xd, tBoc. 
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Figure 2 Reverse-phase HPLC of crude peptide intermediates and purified 
human defensin HNP1 
 
The solvent system employed was acetonitrile/water (both containing 0.1% 
TFA). (a) Crude peptide with one disulphide bond between Cys-1 and Cys-30; 
(b) crude peptide with two disulphide bonds, between Cys-1 and Cys-30 and 
between Cys-4 and Cys-19 ; (c) crude HNP1; (d) purified HNP1. The gradient 
used is indicated by the broken line (% acetonitrile). Peptide samples (C150 
lg) were loaded into an injection loop of 250 l capacity and detected at 230 
nm. 
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Figure 3 Concentration-dependence of loss of viability of Candida albicans 
(DIS) induced by human neutrophil defensins and their analogues 
 
Left panel: a, native HNP1; b, synthetic HNP1; c, synthetic HNP2; d, synthetic 
HNP3. Right panel: a, HNPb; b, HNPc; c, HNPd; d, HNPe; e, HNPa. C. albicans 
cells (DIS) were incubated for 1.5 h at 37°C with defensin peptides (0.05-200 
M) as described in the Experimental section. Loss of cell viability is 
expressed as [1— (cell survival after peptide incubation)/(cell survival in 
buffer alone)] х 100. Each data point is the mean (±S.D.) of duplicate 
determinations from three independent experiments 
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Figure 4 Concentration-dependence of loss of viability of Porphyromonas 
gingivalis strains W50 (left) and 380 (right) induced by human neutrophil 
defensing analogues HNPb (a), HNPc (b), HNPd (c) and HNPe (d) 
 
P. gingivalis cells were incubated for 1.5 h at 37°C with defensin peptides 
(0.05-200 M) as described in the Experimental section. Loss of cell viability 
is expressed as [1 — (cell survival after peptide incubation)/(cell survival in 
buffer alone)] х 100. Each data point is the mean (±S.D.) of duplicate 
determinations from three independent experiments. 
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Figure 5 Concentration-dependence of loss of viability of Actinobacillus 
actinomycetemcomitans strains Y4 (left) and 67 (right) induced by human 
neutrophil defensin analogues HNPb (a), HNPc (b), HNPd (c) and HNPe (d) 
 
A. actinomycetemcomitans cells were incubated for 1.5 h at 37°C with 
defensin peptides (0.05-200 M) as described in the Experimental section. 
Loss of cell viability is expressed as [1 — (cell survival after peptide 
incubation)/(cell survival in buffer alone)] х 100. Each data point is the mean 
(±S.D.) of duplicate determinations from three independent experiments. 
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Figure 6 Concentration-dependence of loss of viability of Streptococcus 
gordonii DL1 (left) and Streptococcus mutans GS5 (right) induced by human 
neutrophil defensin analogues HNPb (a), HNPc (b), HNPd (c) and HNPe (d) 
 
S. gordonii and S. mutans cells were incubated for 1.5 h at 37°C with 
defensin peptides (0.05-200 M) as described in the Experimental section. 
Loss of cell viability is expressed as [1 — (cell survival after peptide 
incubation)/(cell survival in buffer alone)] х 100. Each data point is the mean 
(±S.D.) of duplicate determinations from three independent experiments 
 
 
